Nivolumab,Ipilimumab,Pazopanib,Sunitinib
BMS,Novartis,Pfizer
['nivo', 'kcsm,(-skcsm)', '/ipi', 'rcc,(-irccs),(-srcc),(-urcc)', 'ipilimumab', 'nivolumab']
increased in-situ and immune expression enrich for nivolumab/ipilimumab efficacy in metastatic rcc #esmo2022 #kcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.